Eisai Co Ltd
TSE:4523

Watchlist Manager
Eisai Co Ltd Logo
Eisai Co Ltd
TSE:4523
Watchlist
Price: 4 650 JPY 0.67% Market Closed
Market Cap: 1.3T JPY
Have any thoughts about
Eisai Co Ltd?
Write Note

Relative Value

The Relative Value of one Eisai Co Ltd stock under the Base Case scenario is 7 950.62 JPY. Compared to the current market price of 4 650 JPY, Eisai Co Ltd is Undervalued by 42%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
7 950.62 JPY
Undervaluation 42%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
98
vs Industry
44
Median 3Y
2.7
Median 5Y
3
Industry
2.5
Forward
1.7
vs History
47
vs Industry
9
Median 3Y
46
Median 5Y
41.2
Industry
21.9
Forward
29.8
vs History
31
vs Industry
13
Median 3Y
33.6
Median 5Y
28.8
Industry
16.5
vs History
58
vs Industry
15
Median 3Y
32.5
Median 5Y
33.7
Industry
23.6
vs History
98
vs Industry
37
Median 3Y
2.5
Median 5Y
2.8
Industry
2.1
vs History
98
vs Industry
45
Median 3Y
2.4
Median 5Y
2.7
Industry
2.6
Forward
1.5
vs History
98
vs Industry
61
Median 3Y
3.1
Median 5Y
3.6
Industry
5.2
vs History
73
vs Industry
18
Median 3Y
19.9
Median 5Y
18.6
Industry
13.3
Forward
11.8
vs History
44
vs Industry
11
Median 3Y
31.3
Median 5Y
27.9
Industry
16.6
Forward
19.3
vs History
31
vs Industry
14
Median 3Y
30.5
Median 5Y
26.4
Industry
15.6
vs History
26
vs Industry
8
Median 3Y
18.1
Median 5Y
33.5
Industry
19.1
vs History
98
vs Industry
41
Median 3Y
1.9
Median 5Y
2.2
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Eisai Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Eisai Co Ltd
TSE:4523
1.3T JPY 1.8 40.7 14.4 28.4
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
JP
Eisai Co Ltd
TSE:4523
Average P/E: 33.4
40.7
79%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top